Lack of association between RNASEL Arg462Gln variant and the risk of breast cancer

Files

Lack of association between RNASEL Arg462Gln variant and the risk of breast cancer.pdf (76.12 KB)

Date

2004

Authors

Sevinç, A.
Yannoukakos, D.
Konstantopoulou, I.
Manguoglu, E.
Lüleci, G.
Çolak, T.
Akyerli, C.
Çolakoglu, G.
Tez, M.
Sayek, I.

Editor(s)

Advisor

Supervisor

Co-Advisor

Co-Supervisor

Instructor

Source Title

Anticancer Research

Print ISSN

0250-7005

Electronic ISSN

Publisher

International Institute of Anticancer Research

Volume

24

Issue

4

Pages

2547 - 2549

Language

English

Type

Article

Journal Title

Journal ISSN

Volume Title

Series

Abstract

Background: The RNASEL G1385A variant was recently found to be implicated in the development of prostate cancer. Considering the function of RNase L and the pleiotropic effects of mutations associated with cancer, we sought to investigate whether the RNASEL G1385A variant is a risk factor for breast cancer. Patients and Methods: A total of 453 breast cancer patients and 382 age- and sex-matched controls from Greece and Turkey were analyzed. Genotyping for the RNASEL G1385A variant was performed using an Amplification Refractory Mutation System (ARMS). Results: Statistical evaluation of the RNASEL G1385A genotype distribution among breast cancer patients and controls revealed no significant association between the presence of the risk genotype and the occurrence of breast cancer. Conclusion: Although an increasing number of studies report an association between the RNASEL G1385A variant and prostate cancer risk, this variant does not appear to be implicated in the development of breast cancer.

Course

Other identifiers

Book Title

Keywords

Breast cancer , RNASEL , Arginine , Glutamine , Ribonuclease L , Adolescent , Aged , Amino acid sequence , Amplification refractory mutation system , Article , Breast cancer , Cancer risk , Controlled study , Disease association , Female , Gene amplification , Gene mutation , Genotype , Greece , Human , Human tissue , Major clinical study , Pleiotropy , Priority journal , Protein variant , Risk factor , Turkey (republic) , Adult , Aged , Aged, 80 and over , Alleles , Breast Neoplasms , Case-Control Studies , DNA, Neoplasm , Endoribonucleases , Female , Humans , Middle aged , Mutation , Risk factors

Citation

Permalink

http://hdl.handle.net/11693/24266

item.page.isversionof

Collections

Department of Molecular Biology and Genetics
Institute of Materials Science and Nanotechnology (UNAM)